Axioma
Designs, produces and distributes biosolutions based on complex arrangements of plant extracts.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor investor investor | €0.0 | round |
| N/A | €0.0 | round | |
* | €2.4m | Early VC | |
| Total Funding | 000k | ||
Related Content
Founded in 2012 by CEO Anthony Bugeat, Axioma Biologicals operates within the agricultural biotechnology sector, specializing in the development and industrial production of biosolutions. The company is headquartered in Brive-la-Gaillarde, France, and focuses on creating biostimulants and biocontrol products derived from plant extracts. These products are designed to enhance crop resilience against abiotic stresses such as drought and temperature fluctuations, which are significant factors in yield loss.
Axioma Biologicals' core technology involves proprietary methods for blending active ingredients from plant-based extractions. The resulting formulations stimulate the natural physiological processes in plants, improving nutrient absorption and overall health without the use of synthetic chemicals or NPK (nitrogen, phosphorus, potassium). This approach positions the company as a provider of ecologically conscious alternatives for modern agriculture, including for certified organic farming. The company has successfully obtained market authorizations for its biostimulants, a key differentiator that guarantees the products' efficacy and safety.
The business model is centered on research and development, manufacturing, and white-label distribution. Axioma Biologicals conceives, tests, and produces its biosolutions in its own factories, which have an annual production capacity of over 15 million liters. These finished products are then distributed globally through strategic partnerships with leading agricultural distribution firms. This B2B approach allows the company to reach a broad customer base across various agricultural sectors, including cereals, corn, oilseed, viticulture, and vegetables. The company has pursued an international expansion strategy, establishing a presence in markets such as Australia, North America, and Latin America. To fuel its growth, Axioma has secured significant funding, including a €15 million round in March 2023 from investors like VitiRev Innovation and the BNP Paribas Solar Impulse Venture Fund.
Keywords: biostimulants, biocontrol, agricultural biotechnology, plant extracts, abiotic stress, sustainable agriculture, crop resilience, white-label distribution, agtech, biosolutions